Molecular approaches for the treatment of hemorrhagic fever virus infections

This publication has 109 references indexed in Scilit:

• Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep
  Vaccine, 1991
• Antiviral Activity Spectrum of Nucleoside and Nucleotide Analogues
  Nucleosides and Nucleotides, 1991
• Activity of Dextran Sulfate and Other Polyanionic Polysaccharides Against Human Immunodeficiency Virus
  The Journal of Infectious Diseases, 1988
• Construction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea pigs from a lethal Lassa virus infection
  Virus Research, 1988
• 3-Deazaneplanocin: A new and potent inhibitor of S-adenosylhomocysteine hydrolase and its effects on human promyelocytic leukemia cell line HL-60
  Biochemical and Biophysical Research Communications, 1986
• Lassa Fever
  New England Journal of Medicine, 1986
• Rift Valley fever virus vaccine trial: study of neutralizing antibody response in humans
  Vaccine, 1985
• The broad spectrum antiviral agent ribavirin inhibits capping of mRNA
  Biochemical and Biophysical Research Communications, 1979
• Inhibition of influenza RNA synthesis by virazole (ribavirin)
  Archives of Virology, 1976
• Fluoroimidazoles as antiviral agents and inhibitors of polynucleotide biosynthesis
  Life Sciences, 1975